DSD and TB/HIV services in Zimbabwe

Slides:



Advertisements
Similar presentations
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Advertisements

Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Unit 5: IPT Isoniazid TB Preventive Therapy
National TB/ Leprosy Programme Manager
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Haileyesus Getahun Stop TB Department WHO Re-conceptualizing ICF and IPT: global progress to date 14 th Core Group Meeting of the TB/HIV Working Group,
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
Challenges of Intensified TB case finding among PLHIV : Kenyan experience Dr. J. Sitienei Ministry of Health Kenya.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
Roundtable. Detection and treatment of TB Andrew Black.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Safety Monitoring & Adverse Drug Reactions to Efavirenz and INH Dr Clorata Gwanzura MBChB-UZ, MPH –FETP (UZ)
TB infection control in the era of MDR and XDR TB Haileyesus Getahun Stop TB Department WHO/HQ.
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Dr. Tsitsi Apollo Ministry of Health and Child Care, Zimbabwe
Differentiated Monitoring & Evaluation
A Way out of Directly Observed Therapy (DOT): Community approaches to Self-Administered Treatment for Rifampicin Resistant Tuberculosis in Khayelitsha,
How differentiated care supports “Tx all” and Dr
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Differentiated Service Delivery: Innovating for Impact
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
TB- HIV Collaborative activities in Romania- may 2006 status
Zimbabwe’s shift towards treat all: national country context
Tolerability of Isoniazid Preventive Therapy (IPT) in an HIV infected cohort
Progress with intensified TB Case Finding in Nigeria
Progress in Implementing collaborative TB/HIV activities
Innovating: Looking at VMMC linkages for sexual and reproductive and other health needs Presenter: Dr Mugurungi Director AIDS and TB Programmes MOHCC,
Keeping Kids in the Picture: Pediatric TB in the COPs process
Implementation of the Appointment Spacing Model of Differentiated Service Delivery in Ethiopia: Successes and Challenges Tamrat Assefa1, Zenebe Melaku1,
Dr. Kathure, Weyenga and Langat
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Taking DSD to Scale in Zimbabwe
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
World Health Organization
Pre-conference Meeting Report
Progress in Implementation of TB/HIV Collaborative activities
Tolerability of Isoniazid Preventive therapy Among HIV infected Cohort in Nigeria Folajinmi Oluwasina Strategic Information Unit AIDS Healthcare Foundation,
Enablers for nationwide expansion of collaborative TB/HIV activities
Screening and diagnosing TB in PLHIV: Challenges and ways forward
Integrating TB and HIV care services – Malawi Experiences
Improving Technical Efficiencies:
Collaborative TB/HIV services
ANTIRETROVIRAL TREATMENT IN RESOURCE-LIMITED SETTINGS: PROGRESS & CHALLENGES IN SOUTH AFRICA YOGAN PILLAY DEPARTMENT OF HEALTH, SOUTH AFRICA IAS, 2014.
TB/HIV COLLABORATION IN UGANDA
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Presentation for Second Meeting of the Global TB/HIV Working Group
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Fabio Scano IUATLD Conference Paris, 2003
Multi-disease diagnostic integration
TB Screening and Differentiated Service Delivery: State of the Art
KATUREEBE CORDELIA, MBchB, MMED Pead
CQUIN Call to Action Peter Preko MB, ChB Project Director, CQUIN
Update on global progress in ART
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

DSD and TB/HIV services in Zimbabwe Dr. Tsitsi Apollo, MBChB, MPH, MBA Deputy Director HIV/AIDS and STI, MOHCC 22 July 2019

Presentation Outline Background Progress in Implementing TPT DSD for TB/HIV Opportunities and Challenges Conclusions

Background Zimbabwe remains one of top 8 countries in Africa on world’s top 30 list of countries heavily burdened by TB, TB/HIV and MDR-TB HIV prevalence of 14,6% (ZIMPHIA, 2016) TB prevalence of 221 /100,000 population TB/HIV co- infection rate of 63% (Global TB Report, 2018) 4.6% and 14.2% Rifampicin Resistant- TB among new and re-treatment cases respectively (Zimbabwe National TB Drug Resistance Survey, 2016) Zimbabwe Population: 13 M

TB/HIV Country Context Country adapted 2004 WHO interim policy on collaborative TB/HIV activities Strengthening collaborative mechanisms between national TB and AIDS programmes Reduction of TB burden among PLHIV (3 I’s) Reduction of HIV burden among TB patients The CQUIN Learning Network

Reducing the Burden of TB among PLHIV (3 I’s) Intensified TB Case Finding: Four symptom based screening tool (current cough, fever, weight loss & night sweats) adopted and currently being used to screen all clients for TB Microscopy centres established and microscopists engaged in all districts to support early TB diagnosis A total of 136 plus GeneXpert instruments have been deployed across all districts A sample transportation system was put in place to complement TB diagnosis The CQUIN Learning Network

Roadmap in Implementation of the National ICF/IPT Programme Adaptation processes of the 2011 WHO ICF/IPT Guidelines Revision of M&E Data Reporting and Recording Tools Stakeholder Sensitization meetings at various levels on ICF/IPT Capacity & Skills Building of HCWs to provide ICF/IPT services. Feasibility Phase of ICF/IPT implementation Post Feasibility Phase of ICF/IPT Implementation Jan 2012 – Dec 2013 (10 sites) Jan 2014 – Dec 2018 ( 1280 sites) Prior to Dec 2012 ,only limited to children under 5 years of age who are household contacts of smear-positive TB patients Following adaptation of the 2011 WHO guidelines on ICF/IPT in 2012 , the MOHCC commissioned a feasibility phase in ICF/IPT implementation in 10 selected sites across 5 provinces (Harare, Bulawayo; Mat North, Mat South and Midlands) Indicator 2018 2019 2020 % of adults and children in HIV care started on TB preventive Therapy 15% 25%  40%

The CQUIN Learning Network Setting: 7 pilot sites in Zimbabwe implementing 6 months of isoniazid preventive therapy (IPT) for PLHIV Objectives: To determine, among PLHIV started on IPT, the completion rates for a 6-month course of IPT and factors associated with non-adherence. Design: A retrospective cohort study. Results: Of 578 patients, 81% completed IPT. Of the 112 patients who failed to complete IPT, 60% were lost to follow-up, 30 (27%) stopped treatment, 8 (7%) developed toxicity/adverse reactions, 5 (5%) were documented as having drug stock-outs. Receiving over 2 month supply of isoniazid at the start of treatment was associated with a lower risk of not completing IPT, while missing clinic visits prior to starting IPT was associated with a higher risk of non-completion. Conclusion: IPT completion rates in seven pilot sites of Zimbabwe were comparatively high, showing that IPT roll-out in public health facilities is feasible. Enhanced adherence counselling or active tracing among pre-ART patients and those with a history of loss to follow-up may improve IPT completion rates, along with synchronising IPT and ART resupplies. The CQUIN Learning Network

Zimbabwe National Progress in TPT Implementation, 2012-2018 Intervention: Strengthened counselling of clients on IPT Synchronized ARV and INH pick up visits Spaced meds pick up visits to 3 monthly Changed the INH formulation from 100mg to 300mg tabs to reduce pill burden No. of ART sites offering IPT increased from 10/1560 (<1%) in 2012 to 1,280/1,560 (82%) by 2018 Cumulative no. of ART clients started on IPT increased from 98 in 2012 to 373,819 by 2018

Development of TB and toxicities/side-effects among TPT clients in Zimbabwe, 2012 – 2018 % of clients stopping IPT due to toxicities has declined from a 1.5% peak in 2015 to 0.9% in 2018 % of IPT clients developing TB has declined over time and generally <1%

DSD for TB/HIV Opportunities: Patients considered “stable” for DSD models are also eligible for TPT Peer support and community monitoring systems for ART can be extended to TPT Leveraging on existing robust medicines supply chain for ARVs to support TPT drugs Drug pick up visits for ARVs and TPT have already been synchronized with multi- months scripting Screening for TB during CARG meetings Possibility of TB sputum negative patients to be included in community- based DSD models Potential to utilize existing DSD models to train clients to report adverse events to regulatory authority via e-platforms CARG Group leader screens group members for TB symptoms and fills monitoring form

DSD for TB/HIV Challenges: Zimbabwe TB cases notified below the estimated TB incidence Missed TB cases TB Treatment coverage was 71% in 2017 High burden of MDR-TB “Double” stigma associated with TB and HIV diseases Pill burden needs to be managed Consider use of INH/B6/CTX as an FDC; better formulations needed for 3HP The National TB Program is not quite yet familiar with “DSD” concepts Data: www.who.int/tb/data The CQUIN Learning Network

The CQUIN Learning Network Conclusion: DSD models for TB/HIV are needed especially in high burden TB/HIV countries to address the needs of PLHIV and at high risk of developing TB Opportunities and challenges exist in developing effective models that provide client-centred services that meet the expectations and preferences of clients without compromising their treatment outcomes Investments in operations research are needed to further understand what would be required to inform policy and practice The CQUIN Learning Network

The CQUIN Learning Network Acknowledgements: HIV and TB Department, Zimbabwe, MOHCC Dr Regis Choto, Dr Kudakwashe Takarinda HIV and TB Technical and Funding Partners The CQUIN Learning Network